Faktor Risiko Pasien Coronavirus Disease-19 (Covid-19)
DOI:
https://doi.org/10.53089/medula.v12i4.581Kata Kunci:
Faktor Risiko, Covid-19Abstrak
Coronavirus disease-19 (Covid-19) adalah penyakit yang disebabkan oleh virus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) hingga menyebabkan pandemi di seluruh dunia hingga akhirnya ke Indonesia pada bulan Maret 2020 lalu. Penyakit ini menimbulkan berbagai macam manifestasi klinis dari ringan hingga berat yang salah satunya juga bergantung dari faktor risiko yang dapat memperparah pasien Covid-19 hingga menyebabkan kematian. Faktor risiko yang sering dikaitkan dengan penyakit Covid-19, seperti usia, ras dan etnis, jenis kelamin, obesitas, riwayat penyakit hipertensi, penyakit paru obstruksi kronik (PPOK), dan diabetes melitus. Hal ini juga berkaitan dengan masuknya virus ke dalam tubuh yang menggunakan angiotensin converting enzyme-2 (ACE-2), sehingga menyebabkan berbagai faktor risiko muncul. Artikel ini merupakan tinjauan pustaka yang tersusun dengan menggunakan artikel sebagai referensi yang digunakan antara tahun 2020-2022.
Referensi
Kemenkes. Data Sebaran Covid-19 di Indonesia. 2022. Tersedia dari https://covid19.go.id.
Alkautsar A. Hubungan Penyakit Komorbid dengan Tingkat Keparahan Pasien Covid-19. Jurnal Medika Hutama. 2021. Tersedia dari: https://jurnalmedikahutama.com/in dex.php/JMH/article/view/302.
Ichsan MN, Kusadhiani I, Latuconsina VZ. Hubungan Komorbid dengan Durasi Perawatan pasien Covid-19 pada RS Bayangkara dan RS Tk. II Pro. Dr. JA. Latumen di Kota Ambon tahun 2020. Molucca Medica. 2022.
Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A et al. Covid-19 and Cardiovascular Disease. Circulation AHA Journal. 2020. doi: 10.1161/CIRCULA TIONAHA.120.046941.
CDC. Underlying Medical Conditions Covid-19. Centers for Disease Control and Prevention. 2022. [diperbaharui 5 Mei 2022] Tersedia dari: https://www.cdc.gov/ coronavirus/2019-ncov/hcp/clinicalcare/ underlyingconditions.html.
Kabarriti R, Brodin NP, Maron MI, Chan, Guha, et al. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York. JAMA Netw Open. 2020. doi:10.1001/jamanet workopen.2020.19795.
Ko JY, Danielson ML, Town M, Derado G, Greenlund KJ, Kirley PD, et al. COVID-NET Surveillance Team, Risk Factors for Coronavirus Disease 2019 (COVID-19)–Associated Hospitalization: COVID-19–Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System, Clinical Infectious Diseases. 2021; 72(11): 695-703, doi: https://doi.org/10.1093 /cid/ciaa1419.
Sitorus RJ, Antara NY, Elviani R, Ahmad Z, Hudari H, Sangalang RV. The Risk Factor For Mortality in Covid-19 Patients in Mohammad Hoesin Hospital, Palembang, Indonesia. Jurnal Ilmu Kesehatan Masyarakat. 2021. doi: https://doi.org/10.26553/jikm.2021.12.1.69-76.
Gao YD, Ding M, Dong X, Zhang JJ, Azkur AK, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021. doi: https://doi.org/10.1111/all.14657.
Gao F, Zheng KI, Wang XB, Sun QF, Pan KH, Wang TY, et al. Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care. 2020. doi: https://doi.org/10.2337/dc20-0682.
Matsushita K, Ding N, Kou M, Hu X, Chen M, Gao Y, et al. The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis. Global heart. 2020. doi: https:// doi.org /10.5334/gh.814.
Fadl N, Ali E, Salem TZ. COVID-19: Risk Factors Associated with Infectivity and Severity. Scandinavian Journal of Immunology. 2021. doi:
https://doi.org/10.1111/sji.13039.
Zhang JX, Dong YY, Cao YD, You YB, Yang YQ, Yan CA et al. Clinical Characteristics of 140 patients infecter with SARS-CoV-2 in Wuhan China. Wiley Online Library Journal. 2020.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. doi: 10.1016/S0140-6736(20)30566-3.
Gerayeli FV, Milne S, Cheung C, Li X, Yang CWT, Tam A, et al. COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis, EClinical Medicine. 2021. doi: https://doi.org/10.26553/jikm.2021.12.1.69-76.
Erener, S. Diabetes, infection risk and COVID-19, Molecular Metabolism. 2020. doi: https://doi.org/10.1016/j.molmet. 2020.101044.
Huang I, Lim M, Pranata R,. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020. doi: https://doi.org/10.1016/j.dsx.2020.04.018
##submission.downloads##
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2023 Medula
Artikel ini berlisensiCreative Commons Attribution-ShareAlike 4.0 International License.
